BridgeBio Pharma (BBIO) Tax Rate (2024 - 2025)
BridgeBio Pharma recorded quarterly Tax Rate of 0.06% in Q4 2025, down 92.34% quarter-over-quarter from 0.8% in Q3 2025, and up 49.0% year-over-year from 0.04% in Q4 2024.
BridgeBio Pharma's Tax Rate history runs 2 years deep, the most recent figure standing at 0.06% for Q4 2025.
- In Q4 2025, Tax Rate rose 49.0% year-over-year to 0.06%; the TTM figure through Dec 2025 stood at 0.24% (changed N/A YoY), while the FY2025 annual figure was 0.06%, up 15.0% from the prior year.
- Tax Rate came in at 0.06% for Q4 2025 at BridgeBio Pharma, down from 0.8% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 0.8% in Q3 2025 to a low of 1.16% in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 57.14 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 5.61 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 17.68 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -6.79 |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 12.51 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 7.07 |
| 10 | BridgeBio Pharma | 12.91 Bn | 11.98 Bn | 184.58 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.06 |
| Dec 31, 2025 | 0.06 |
| Sep 30, 2025 | 0.80 |
| Sep 30, 2025 | 0.80 |
| Jun 30, 2025 | -1.16 |
| Jun 30, 2025 | -1.16 |
| Dec 31, 2024 | -0.43 |
| Dec 31, 2024 | -0.43 |